CIPROFLOXACIN HYDROCHLORIDE

CIPROFLOXACIN HYDROCHLORIDE was reported 97704 times

CIPROFLOXACIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOTAL LUNG CAPACITY INCREASED 160 0.5882
1 VAGINAL FLATULENCE 177 0.5842
2 TENDON DISCOMFORT 258 0.3417
3 MUSCULOSKELETAL INJURY 83 0.3374
4 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 154 0.2945
5 TENDON PAIN 2059 0.2717
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 192 0.1808
7 TENDON DISORDER 1163 0.1782
8 HYPERPARATHYROIDISM SECONDARY 417 0.1663
9 NEPHROGENIC ANAEMIA 755 0.1628
10 NASAL OEDEMA 270 0.1493
11 TENDONITIS 2295 0.1481
12 DYSBIOSIS 121 0.1474
13 REBOUND ACID HYPERSECRETION 437 0.1443
14 FEMALE GENITAL TRACT FISTULA 246 0.1439
15 SMALL FIBRE NEUROPATHY 94 0.1274
16 JOINT NOISE 213 0.1083
17 TENDON RUPTURE 1312 0.1062
18 POUCHITIS 91 0.1057
19 JOINT CREPITATION 198 0.0997
20 CHRONIC FATIGUE SYNDROME 129 0.0925
21 TENDON INJURY 341 0.0916
22 CONNECTIVE TISSUE DISORDER 126 0.0887
23 RADICULOPATHY 231 0.0876
24 PROCTITIS 235 0.0838
25 LIGAMENT DISORDER 76 0.0835
26 EPICONDYLITIS 120 0.0795
27 END STAGE RENAL DISEASE 1425 0.0781
28 OESOPHAGEAL SPASM 140 0.0759
29 FISTULA DISCHARGE 93 0.0736
30 PSEUDOMEMBRANOUS COLITIS 146 0.0653
31 MUSCLE RUPTURE 242 0.0621
32 RECTAL ABSCESS 104 0.0619
33 CLOSTRIDIUM TEST POSITIVE 134 0.0607
34 CHRONIC SINUSITIS 227 0.0604
35 CHRONIC KIDNEY DISEASE 4561 0.0600
36 WEIGHT BEARING DIFFICULTY 156 0.0579
37 PLANTAR FASCIITIS 194 0.0578
38 CLOSTRIDIUM DIFFICILE COLITIS 588 0.0554
39 TUBULOINTERSTITIAL NEPHRITIS 1010 0.0538
40 ANAL FISTULA 281 0.0526
41 PROSTATITIS 160 0.0525
42 RHINITIS ALLERGIC 233 0.0523
43 LOSS OF EMPLOYMENT 157 0.0519
44 FOOD INTOLERANCE 189 0.0516
45 PATHOGEN RESISTANCE 462 0.0506
46 TOXIC EPIDERMAL NECROLYSIS 769 0.0506
47 PULMONARY PAIN 141 0.0483
48 ANAL FISSURE 257 0.0479
49 FUNGAEMIA 75 0.0476
50 ANAL ABSCESS 253 0.0469
51 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 249 0.0457
52 PSEUDOMONAS INFECTION 386 0.0450
53 HYPERACUSIS 167 0.0448
54 HENOCH-SCHONLEIN PURPURA 96 0.0439
55 JAUNDICE CHOLESTATIC 155 0.0438
56 RENAL TUBULAR NECROSIS 428 0.0436
57 FISTULA 487 0.0433
58 TENOSYNOVITIS 119 0.0431
59 BRONCHIECTASIS 281 0.0417
60 CHOLECYSTITIS CHRONIC 275 0.0410
61 SKIN INJURY 131 0.0395
62 LUNG CONSOLIDATION 109 0.0389
63 ENTEROCOCCAL INFECTION 186 0.0385
64 MUSCLE CONTRACTIONS INVOLUNTARY 135 0.0384
65 NASAL POLYPS 189 0.0383
66 ABSCESS INTESTINAL 82 0.0381
67 LYMPHOEDEMA 261 0.0377
68 TORSADE DE POINTES 292 0.0372
69 SARCOIDOSIS 175 0.0368
70 SPUTUM INCREASED 79 0.0365
71 MUSCLE ATROPHY 454 0.0358
72 OESOPHAGEAL PAIN 141 0.0357
73 KLEBSIELLA INFECTION 172 0.0340
74 BLADDER PAIN 106 0.0334
75 NEUROPATHY PERIPHERAL 3157 0.0332
76 NERVE INJURY 369 0.0332
77 SYSTEMIC CANDIDA 82 0.0326
78 NEURALGIA 788 0.0324
79 CUTANEOUS VASCULITIS 118 0.0323
80 RENAL INJURY 959 0.0323
81 ESCHERICHIA URINARY TRACT INFECTION 137 0.0322
82 CARTILAGE INJURY 79 0.0320
83 CLOSTRIDIUM DIFFICILE INFECTION 692 0.0317
84 HYPOMANIA 116 0.0315
85 ABDOMINAL ABSCESS 139 0.0314
86 ACUTE KIDNEY INJURY 4806 0.0314
87 RASH MORBILLIFORM 87 0.0314
88 DYSAESTHESIA 96 0.0313
89 WOUND COMPLICATION 106 0.0309
90 ROTATOR CUFF SYNDROME 390 0.0303
91 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 781 0.0303
92 CYSTIC FIBROSIS 167 0.0301
93 AUTONOMIC NERVOUS SYSTEM IMBALANCE 88 0.0301
94 MUSCLE TWITCHING 679 0.0294
95 TINNITUS 1353 0.0294
96 ASPERGILLUS INFECTION 193 0.0294
97 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 228 0.0293
98 MULTIPLE-DRUG RESISTANCE 91 0.0293
99 ORAL CANDIDIASIS 380 0.0288
100 PYELONEPHRITIS 249 0.0287
101 PHYSICAL DISABILITY 127 0.0287
102 ECONOMIC PROBLEM 430 0.0283
103 BONE EROSION 100 0.0282
104 HALLUCINATIONS, MIXED 118 0.0280
105 TOXIC ENCEPHALOPATHY 142 0.0280
106 ANXIETY DISORDER 91 0.0272
107 DERMATITIS EXFOLIATIVE 136 0.0272
108 CARDIAC MURMUR 235 0.0271
109 LIGAMENT RUPTURE 119 0.0269
110 ABSCESS 429 0.0269
111 ESCHERICHIA INFECTION 221 0.0268
112 CYSTITIS 851 0.0267
113 PNEUMONIA FUNGAL 105 0.0266
114 CLOSTRIDIAL INFECTION 90 0.0266
115 NEUTROPENIC SEPSIS 189 0.0264
116 DRUG RESISTANCE 676 0.0263
117 RENAL FAILURE 3450 0.0260
118 PROCTALGIA 167 0.0259
119 FAECAL CALPROTECTIN INCREASED 82 0.0259
120 CREPITATIONS 77 0.0258
121 STEVENS-JOHNSON SYNDROME 568 0.0255
122 ATELECTASIS 246 0.0254
123 ACUTE GRAFT VERSUS HOST DISEASE 116 0.0253
124 OEDEMA 1371 0.0253
125 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 96 0.0251
126 FLANK PAIN 235 0.0250
127 OLIGURIA 155 0.0249
128 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 81 0.0249
129 UROSEPSIS 230 0.0249
130 DRUG LEVEL BELOW THERAPEUTIC 136 0.0246
131 STAPHYLOCOCCAL SEPSIS 120 0.0243
132 EXERCISE TOLERANCE DECREASED 139 0.0241
133 IMPAIRED WORK ABILITY 513 0.0240
134 CANDIDIASIS 96 0.0239
135 BACTERAEMIA 283 0.0238
136 DIVERTICULITIS 656 0.0236
137 WHEEZING 1396 0.0235
138 VITREOUS FLOATERS 231 0.0235
139 NEPHROPATHY 219 0.0234
140 ANHEDONIA 611 0.0232
141 RESPIRATORY TRACT INFECTION 605 0.0232
142 FOOD ALLERGY 177 0.0229
143 COLITIS 863 0.0227
144 HEPATITIS CHOLESTATIC 137 0.0227
145 PANIC ATTACK 828 0.0227
146 RASH MACULO-PAPULAR 505 0.0227
147 GROIN PAIN 196 0.0223
148 PHOTOSENSITIVITY REACTION 367 0.0222
149 NECROTISING FASCIITIS 78 0.0221
150 SPINAL OSTEOARTHRITIS 194 0.0221
151 THROMBOCYTOSIS 80 0.0218
152 APLASTIC ANAEMIA 114 0.0218
153 POLYNEUROPATHY 261 0.0218
154 PHLEBITIS 111 0.0217
155 HYDRONEPHROSIS 161 0.0215
156 SUBCUTANEOUS ABSCESS 103 0.0215
157 ABDOMINAL TENDERNESS 106 0.0213
158 EOSINOPHILIA 374 0.0213
159 PURULENT DISCHARGE 91 0.0213
160 FEBRILE NEUTROPENIA 1411 0.0212
161 APHTHOUS ULCER 164 0.0211
162 LEUKOCYTOSIS 382 0.0211
163 FIBROMYALGIA 513 0.0211
164 ENDOPHTHALMITIS 126 0.0210
165 DIVERTICULUM 148 0.0208
166 CHOLECYSTITIS ACUTE 118 0.0208
167 PARAESTHESIA ORAL 299 0.0207
168 CANDIDA INFECTION 350 0.0207
169 VAGINAL DISCHARGE 209 0.0206
170 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 104 0.0205
171 TENDERNESS 212 0.0203
172 STAPHYLOCOCCAL BACTERAEMIA 88 0.0202
173 DRUG INTERACTION 3207 0.0202
174 HEPATIC ENCEPHALOPATHY 188 0.0201
175 DIVERTICULUM INTESTINAL 88 0.0201
176 NEUROLOGICAL SYMPTOM 115 0.0201
177 NECROSIS 111 0.0199
178 MUSCLE FATIGUE 84 0.0198
179 LUNG INFILTRATION 170 0.0192
180 GUILLAIN-BARRE SYNDROME 93 0.0192
181 ENTERITIS 123 0.0192
182 SEPTIC SHOCK 835 0.0192
183 VASCULAR DEVICE INFECTION 87 0.0192
184 WALKING AID USER 126 0.0191
185 MULTI-ORGAN FAILURE 330 0.0191
186 GRAFT VERSUS HOST DISEASE 137 0.0190
187 RENAL CYST 151 0.0190
188 BRONCHOPULMONARY ASPERGILLOSIS 147 0.0189
189 RENAL FAILURE ACUTE 799 0.0188
190 FEBRILE BONE MARROW APLASIA 80 0.0188
191 TRICUSPID VALVE INCOMPETENCE 149 0.0187
192 BURNING SENSATION 1303 0.0186
193 BLOOD PRESSURE DIASTOLIC DECREASED 137 0.0185
194 DRUG LEVEL ABOVE THERAPEUTIC 85 0.0185
195 BLOOD CREATINE INCREASED 82 0.0185
196 URINE ABNORMALITY 84 0.0185
197 MUSCLE TIGHTNESS 297 0.0183
198 PERIPHERAL SENSORY NEUROPATHY 107 0.0183
199 WHEELCHAIR USER 81 0.0182
200 NERVOUS SYSTEM DISORDER 568 0.0182
201 MYOCLONUS 217 0.0182
202 MUCOSAL INFLAMMATION 475 0.0181
203 GASTROINTESTINAL INFLAMMATION 142 0.0181
204 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 160 0.0181
205 ABSCESS LIMB 77 0.0180
206 QUALITY OF LIFE DECREASED 242 0.0180
207 ANURIA 155 0.0180
208 GASTROINTESTINAL PAIN 198 0.0180
209 FREQUENT BOWEL MOVEMENTS 486 0.0180
210 ENDOCARDITIS 92 0.0179
211 KIDNEY INFECTION 351 0.0179
212 HEPATIC CYTOLYSIS 228 0.0179
213 HEPATIC STEATOSIS 332 0.0178
214 LUNG NEOPLASM 76 0.0178
215 MUSCLE DISORDER 144 0.0178
216 ODYNOPHAGIA 106 0.0177
217 DEVICE RELATED INFECTION 273 0.0177
218 URINARY TRACT INFECTION 3014 0.0177
219 CROHN'S DISEASE 121 0.0176
220 PHOTOPHOBIA 332 0.0176
221 BURSITIS 214 0.0176
222 METABOLIC DISORDER 102 0.0175
223 PROTHROMBIN TIME PROLONGED 105 0.0175
224 DERMATITIS BULLOUS 127 0.0175
225 FORMICATION 122 0.0175
226 MULTIPLE ORGAN DYSFUNCTION SYNDROME 496 0.0175
227 MYOSITIS 157 0.0175
228 MULTIPLE ALLERGIES 137 0.0175
229 MULTIPLE INJURIES 110 0.0175
230 BENIGN PROSTATIC HYPERPLASIA 90 0.0174
231 INFLAMMATORY MARKER INCREASED 86 0.0173
232 PARAESTHESIA 2719 0.0173
233 EAR PAIN 334 0.0172
234 GASTROINTESTINAL INFECTION 154 0.0172
235 MYALGIA 2914 0.0171
236 MUSCULOSKELETAL PAIN 895 0.0171
237 GINGIVITIS 92 0.0170
238 MITRAL VALVE INCOMPETENCE 193 0.0170
239 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 175 0.0170
240 VAGINAL INFECTION 80 0.0170
241 STAPHYLOCOCCAL INFECTION 560 0.0170
242 NEPHROPATHY TOXIC 189 0.0168
243 MUSCULAR WEAKNESS 1908 0.0168
244 CHOLECYSTITIS 200 0.0168
245 MYOPATHY 145 0.0168
246 OBESITY 266 0.0167
247 CHOLELITHIASIS 545 0.0166
248 DYSURIA 611 0.0166
249 GASTROOESOPHAGEAL REFLUX DISEASE 1333 0.0165
250 PATHOLOGICAL FRACTURE 84 0.0165
251 RALES 96 0.0165
252 PURPURA 146 0.0165
253 HYPERBILIRUBINAEMIA 170 0.0164
254 MALNUTRITION 183 0.0163
255 VASCULITIS 190 0.0163
256 SENSORY DISTURBANCE 259 0.0161
257 MENISCUS INJURY 99 0.0161
258 HAEMATOCRIT DECREASED 318 0.0160
259 BLOOD BILIRUBIN INCREASED 431 0.0159
260 SMALL INTESTINAL OBSTRUCTION 196 0.0159
261 AORTIC ANEURYSM 121 0.0159
262 JOINT DISLOCATION 168 0.0159
263 CHOLESTASIS 305 0.0159
264 SLEEP APNOEA SYNDROME 303 0.0159
265 DRUG LEVEL DECREASED 161 0.0158
266 BREATH SOUNDS ABNORMAL 78 0.0158
267 THERMAL BURN 112 0.0158
268 PANCYTOPENIA 881 0.0157
269 MACULAR DEGENERATION 187 0.0156
270 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 78 0.0156
271 ELECTROCARDIOGRAM QT PROLONGED 562 0.0156
272 VENOOCCLUSIVE LIVER DISEASE 77 0.0156
273 INTERVERTEBRAL DISC DEGENERATION 144 0.0155
274 RENAL FAILURE CHRONIC 119 0.0155
275 C-REACTIVE PROTEIN ABNORMAL 99 0.0154
276 HAEMATURIA 528 0.0154
277 SWOLLEN TONGUE 481 0.0154
278 HAEMODYNAMIC INSTABILITY 117 0.0153
279 TEMPERATURE INTOLERANCE 158 0.0153
280 HAEMOLYTIC ANAEMIA 137 0.0153
281 SPUTUM DISCOLOURED 145 0.0153
282 ANORECTAL DISCOMFORT 81 0.0152
283 HYPOVOLAEMIA 89 0.0152
284 OSTEOMYELITIS 275 0.0152
285 BACTERIAL INFECTION 283 0.0152
286 DRUG LEVEL INCREASED 251 0.0151
287 BLOOD ALBUMIN DECREASED 120 0.0151
288 PETECHIAE 157 0.0150
289 CATATONIA 79 0.0150
290 EXTRASYSTOLES 105 0.0150
291 HYPOAESTHESIA 2243 0.0150
292 NIGHT SWEATS 482 0.0149
293 RENAL PAIN 158 0.0149
294 BODY TEMPERATURE DECREASED 146 0.0148
295 INTERNATIONAL NORMALISED RATIO INCREASED 422 0.0148
296 ANXIETY 4211 0.0148
297 POST-TRAUMATIC STRESS DISORDER 99 0.0148
298 OSTEOPENIA 224 0.0147
299 ELECTROLYTE IMBALANCE 171 0.0147
300 JOINT STIFFNESS 385 0.0147
301 OBSTRUCTIVE AIRWAYS DISORDER 163 0.0146
302 JOINT EFFUSION 101 0.0146
303 IMPAIRED QUALITY OF LIFE 210 0.0146
304 DECUBITUS ULCER 119 0.0146
305 C-REACTIVE PROTEIN INCREASED 531 0.0146
306 CACHEXIA 75 0.0146
307 BLOOD PRESSURE SYSTOLIC INCREASED 282 0.0144
308 SEPSIS 1610 0.0144
309 PANIC REACTION 104 0.0144
310 ABNORMAL FAECES 118 0.0144
311 INJURY 1012 0.0144
312 ACUTE RESPIRATORY DISTRESS SYNDROME 254 0.0143
313 INTESTINAL ISCHAEMIA 79 0.0143
314 MOUTH ULCERATION 302 0.0143
315 TOXIC SKIN ERUPTION 144 0.0143
316 ABDOMINAL PAIN LOWER 360 0.0142
317 ARTERIOSCLEROSIS CORONARY ARTERY 94 0.0142
318 SENSORY LOSS 114 0.0141
319 VENTRICULAR EXTRASYSTOLES 147 0.0141
320 HEPATOTOXICITY 315 0.0141
321 EAR DISCOMFORT 145 0.0141
322 PERONEAL NERVE PALSY 80 0.0141
323 NECK PAIN 786 0.0140
324 PERIPHERAL COLDNESS 193 0.0140
325 DISSEMINATED INTRAVASCULAR COAGULATION 197 0.0140
326 MUSCLE STRAIN 121 0.0140
327 CARDIOMEGALY 172 0.0140
328 ABDOMINAL PAIN 3242 0.0139
329 DIARRHOEA HAEMORRHAGIC 130 0.0139
330 TACHYPNOEA 189 0.0139
331 MUSCULOSKELETAL CHEST PAIN 214 0.0138
332 SPINAL PAIN 162 0.0138
333 JAUNDICE 372 0.0138
334 GALLBLADDER DISORDER 245 0.0137
335 HEART RATE IRREGULAR 310 0.0137
336 MEDICATION ERROR 762 0.0137
337 MUSCULOSKELETAL DISCOMFORT 235 0.0136
338 HYPOMAGNESAEMIA 190 0.0136
339 FAECES SOFT 99 0.0136
340 ARTHRALGIA 5647 0.0136
341 AGRANULOCYTOSIS 252 0.0135
342 NEUROTOXICITY 237 0.0135
343 COAGULOPATHY 225 0.0135
344 ACUTE HEPATIC FAILURE 184 0.0135
345 HAEMATOCHEZIA 743 0.0134
346 ABORTION SPONTANEOUS 539 0.0134
347 SCOLIOSIS 83 0.0134
348 HYPERLIPIDAEMIA 160 0.0134
349 ANGIOPATHY 75 0.0134
350 HIATUS HERNIA 173 0.0133
351 ECCHYMOSIS 91 0.0133
352 SKIN WARM 77 0.0132
353 PAIN IN EXTREMITY 3898 0.0132
354 ABNORMAL LOSS OF WEIGHT 90 0.0132
355 NEPHROLITHIASIS 604 0.0132
356 DRUG ERUPTION 233 0.0131
357 HYPERAESTHESIA 108 0.0131
358 VULVOVAGINAL BURNING SENSATION 80 0.0131
359 URINARY RETENTION 437 0.0131
360 URINE ODOUR ABNORMAL 77 0.0131
361 CYTOMEGALOVIRUS INFECTION 217 0.0130
362 RECTAL HAEMORRHAGE 560 0.0130
363 INFLAMMATION 671 0.0130
364 APPETITE DISORDER 86 0.0130
365 SCHIZOPHRENIA 157 0.0129
366 ABASIA 319 0.0129
367 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 123 0.0129
368 HYPOKALAEMIA 593 0.0128
369 LIGAMENT SPRAIN 127 0.0128
370 DISTURBANCE IN ATTENTION 692 0.0128
371 RENAL IMPAIRMENT 1078 0.0128
372 BRAIN FOG 201 0.0128
373 DRUG-INDUCED LIVER INJURY 402 0.0128
374 POST PROCEDURAL INFECTION 104 0.0128
375 BLOOD CREATININE INCREASED 833 0.0127
376 HAEMODIALYSIS 107 0.0127
377 PSYCHOTIC DISORDER 376 0.0127
378 RHABDOMYOLYSIS 530 0.0127
379 SINUS TACHYCARDIA 180 0.0127
380 HEPATOMEGALY 124 0.0126
381 MICTURITION URGENCY 144 0.0126
382 BLOOD ALKALINE PHOSPHATASE INCREASED 313 0.0126
383 HALLUCINATION 942 0.0125
384 BLOOD UREA INCREASED 209 0.0125
385 COLITIS ISCHAEMIC 84 0.0124
386 FUNGAL INFECTION 415 0.0124
387 ASTHMA 1404 0.0124
388 BEDRIDDEN 163 0.0124
389 PYREXIA 4288 0.0124
390 PHARYNGITIS 153 0.0123
391 MENTAL STATUS CHANGES 342 0.0123
392 IRRITABLE BOWEL SYNDROME 264 0.0123
393 PALPITATIONS 1440 0.0123
394 HEART RATE DECREASED 431 0.0123
395 DEFAECATION URGENCY 86 0.0123
396 THROMBOCYTOPENIA 1372 0.0123
397 OESOPHAGITIS 134 0.0123
398 PARANOIA 211 0.0122
399 DEPRESSION 2781 0.0122
400 ATAXIA 145 0.0122
401 CIRCULATORY COLLAPSE 208 0.0122
402 RED BLOOD CELL SEDIMENTATION RATE INCREASED 135 0.0122
403 PAROSMIA 92 0.0122
404 ACTIVITIES OF DAILY LIVING IMPAIRED 240 0.0121
405 POLYURIA 99 0.0121
406 BLOOD URINE PRESENT 229 0.0121
407 HAEMORRHOIDS 235 0.0120
408 MUSCULOSKELETAL DISORDER 229 0.0120
409 POSTOPERATIVE WOUND INFECTION 81 0.0120
410 GASTROENTERITIS 175 0.0120
411 CYTOKINE RELEASE SYNDROME 240 0.0120
412 WOUND INFECTION 131 0.0120
413 GENERALISED OEDEMA 148 0.0119
414 DYSSTASIA 347 0.0119
415 HEPATIC FAILURE 358 0.0119
416 MUSCLE INJURY 98 0.0118
417 ARRHYTHMIA 560 0.0118
418 SWELLING FACE 768 0.0118
419 ANAL INCONTINENCE 106 0.0118
420 HAEMOLYSIS 91 0.0118
421 URINE OUTPUT DECREASED 103 0.0118
422 FACIAL PAIN 105 0.0118
423 DENTAL CARIES 130 0.0117
424 PULMONARY MASS 175 0.0117
425 BLOOD PRESSURE FLUCTUATION 281 0.0117
426 RESPIRATORY DISTRESS 323 0.0117
427 VENTRICULAR TACHYCARDIA 193 0.0117
428 CELLULITIS 589 0.0117
429 PULMONARY CONGESTION 154 0.0117
430 ACUTE MYELOID LEUKAEMIA 182 0.0117
431 OSTEOARTHRITIS 495 0.0117
432 DELIRIUM 405 0.0117
433 BODY TEMPERATURE INCREASED 238 0.0117
434 PHARYNGEAL SWELLING 114 0.0116
435 PNEUMONIA 3751 0.0116
436 GAIT DISTURBANCE 2216 0.0116
437 MENINGITIS 77 0.0115
438 ARTHROPATHY 640 0.0115
439 EXOSTOSIS 105 0.0115
440 INTESTINAL PERFORATION 129 0.0115
441 LOWER RESPIRATORY TRACT INFECTION 522 0.0115
442 ERYTHEMA MULTIFORME 107 0.0115
443 SPLENOMEGALY 134 0.0114
444 CARPAL TUNNEL SYNDROME 160 0.0114
445 LYMPHADENOPATHY 404 0.0114
446 RASH PUSTULAR 83 0.0114
447 ACUTE RESPIRATORY FAILURE 219 0.0114
448 BONE DISORDER 207 0.0113
449 RESPIRATORY FAILURE 828 0.0113
450 UVEITIS 154 0.0113
451 LOCALISED INFECTION 273 0.0113
452 ARTERIOSCLEROSIS 106 0.0113
453 ENCEPHALOPATHY 275 0.0112
454 HYPOALBUMINAEMIA 87 0.0112
455 TACHYCARDIA 993 0.0112
456 MUSCULOSKELETAL STIFFNESS 979 0.0112
457 UPPER-AIRWAY COUGH SYNDROME 92 0.0112
458 EYE PAIN 628 0.0111
459 PAIN IN JAW 315 0.0111
460 CHROMATURIA 251 0.0111
461 FAECES DISCOLOURED 241 0.0111
462 LEUKOPENIA 556 0.0111
463 SINUS CONGESTION 150 0.0111
464 VITAMIN D DEFICIENCY 108 0.0111
465 RHINITIS 89 0.0110
466 RESTLESSNESS 402 0.0110
467 BLOOD DISORDER 88 0.0110
468 NIGHTMARE 380 0.0110
469 PRODUCTIVE COUGH 524 0.0110
470 METABOLIC ACIDOSIS 351 0.0110
471 DEAFNESS 287 0.0110
472 HYPONATRAEMIA 616 0.0109
473 EYELID OEDEMA 127 0.0109
474 COORDINATION ABNORMAL 152 0.0109
475 OEDEMA PERIPHERAL 1328 0.0109
476 MOTOR DYSFUNCTION 111 0.0109
477 GENERALISED TONIC-CLONIC SEIZURE 180 0.0109
478 DECREASED ACTIVITY 117 0.0108
479 GAIT INABILITY 362 0.0108
480 VENTRICULAR FIBRILLATION 120 0.0108
481 URINARY INCONTINENCE 320 0.0108
482 APHASIA 325 0.0108
483 PARALYSIS 154 0.0107
484 DEHYDRATION 1429 0.0107
485 NOCTURIA 130 0.0107
486 DYSPNOEA EXERTIONAL 402 0.0107
487 PSYCHOLOGICAL TRAUMA 92 0.0106
488 HAEMATOMA 276 0.0106
489 COLITIS ULCERATIVE 475 0.0106
490 ILEUS 132 0.0106
491 HEPATOCELLULAR INJURY 150 0.0106
492 WHITE BLOOD CELL COUNT INCREASED 405 0.0105
493 TOOTH INFECTION 139 0.0105
494 ANAEMIA 2010 0.0105
495 GASTRITIS 277 0.0105
496 CONFUSIONAL STATE 1701 0.0105
497 MENTAL DISORDER 458 0.0105
498 LIVER FUNCTION TEST ABNORMAL 306 0.0105
499 PELVIC PAIN 191 0.0105
500 JOINT SWELLING 1267 0.0105
501 DYSPHONIA 613 0.0105
502 NEUTROPENIA 1424 0.0105
503 PLEURAL EFFUSION 634 0.0104
504 ASCITES 306 0.0104
505 ANGIOEDEMA 460 0.0104
506 CHEST PAIN 1921 0.0104
507 DYSPEPSIA 1019 0.0103
508 HYPERKALAEMIA 363 0.0103
509 LIMB DISCOMFORT 320 0.0103
510 HEAD DISCOMFORT 183 0.0103
511 EOSINOPHIL COUNT INCREASED 86 0.0103
512 FACE OEDEMA 174 0.0103
513 CONTRAINDICATED PRODUCT ADMINISTERED 312 0.0103
514 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 494 0.0103
515 ATRIAL FLUTTER 82 0.0103
516 RESPIRATORY RATE INCREASED 91 0.0102
517 SLEEP DISORDER 723 0.0102
518 LUNG INFECTION 159 0.0102
519 HYPOTONIA 102 0.0102
520 SKIN LESION 280 0.0102
521 THINKING ABNORMAL 189 0.0101
522 INCONTINENCE 107 0.0101
523 TUMOUR LYSIS SYNDROME 89 0.0101
524 PAIN 6199 0.0101
525 HYPOXIA 355 0.0101
526 IRON DEFICIENCY ANAEMIA 93 0.0101
527 BLADDER DISORDER 100 0.0101
528 CHOLECYSTECTOMY 115 0.0101
529 INTERVERTEBRAL DISC PROTRUSION 220 0.0101
530 DEFORMITY 94 0.0100
531 BRONCHITIS 744 0.0100
532 BACK PAIN 2335 0.0100
533 ANAPHYLACTIC REACTION 555 0.0100
534 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 524 0.0100
535 BLOOD LACTATE DEHYDROGENASE INCREASED 159 0.0100
536 SKIN ULCER 259 0.0100
537 BALANCE DISORDER 866 0.0100
538 SECRETION DISCHARGE 125 0.0100
539 POOR VENOUS ACCESS 103 0.0099
540 BLOOD IRON DECREASED 118 0.0099
541 BLOOD POTASSIUM DECREASED 298 0.0099
542 THROAT TIGHTNESS 268 0.0099
543 MENTAL IMPAIRMENT 240 0.0099
544 GAMMA-GLUTAMYLTRANSFERASE INCREASED 219 0.0099
545 ALANINE AMINOTRANSFERASE INCREASED 606 0.0099
546 BLOOD MAGNESIUM DECREASED 85 0.0098
547 EYE INFECTION 111 0.0098
548 FEAR 264 0.0098
549 CARDIOVASCULAR DISORDER 248 0.0098
550 WOUND 272 0.0097
551 ORTHOSTATIC HYPOTENSION 169 0.0097
552 OVARIAN CYST 97 0.0097
553 AGITATION 708 0.0096
554 DISORIENTATION 382 0.0096
555 VOMITING 4514 0.0096
556 GASTROINTESTINAL DISORDER 860 0.0096
557 INFECTION 1388 0.0096
558 DRUG INTOLERANCE 925 0.0096
559 DEEP VEIN THROMBOSIS 622 0.0096
560 NEUTROPHIL COUNT INCREASED 98 0.0096
561 INSOMNIA 2548 0.0096
562 EAR INFECTION 254 0.0095
563 HAEMOPTYSIS 266 0.0095
564 HALLUCINATION, VISUAL 201 0.0095
565 MASS 133 0.0095
566 MUSCLE SPASMS 1746 0.0095
567 UPPER GASTROINTESTINAL HAEMORRHAGE 160 0.0095
568 HEPATITIS 243 0.0095
569 SKIN INFECTION 106 0.0094
570 CONDITION AGGRAVATED 2873 0.0094
571 FEELING COLD 263 0.0094
572 ASTHENIA 3545 0.0094
573 SINUS BRADYCARDIA 91 0.0094
574 BLOOD SODIUM DECREASED 177 0.0094
575 TOOTHACHE 170 0.0094
576 CHILLS 1100 0.0094
577 GENERAL PHYSICAL HEALTH DETERIORATION 1084 0.0094
578 HAEMOGLOBIN DECREASED 962 0.0094
579 SCAR 160 0.0093
580 TOOTH ABSCESS 95 0.0093
581 TRANSAMINASES INCREASED 207 0.0093
582 SPINAL DISORDER 88 0.0093
583 ASPARTATE AMINOTRANSFERASE INCREASED 492 0.0093
584 IMMUNE SYSTEM DISORDER 122 0.0092
585 SEASONAL ALLERGY 131 0.0092
586 GOUT 166 0.0092
587 DIPLOPIA 240 0.0092
588 ABDOMINAL PAIN UPPER 1898 0.0092
589 WEIGHT DECREASED 2570 0.0092
590 DIARRHOEA 5935 0.0092
591 TREMOR 1526 0.0092
592 OSTEOPOROSIS 378 0.0092
593 BLISTER 516 0.0092
594 JOINT RANGE OF MOTION DECREASED 123 0.0092
595 ORAL PAIN 205 0.0091
596 IMPAIRED DRIVING ABILITY 104 0.0091
597 INFUSION SITE ERYTHEMA 77 0.0091
598 JOINT INJURY 195 0.0091
599 EMOTIONAL DISTRESS 1105 0.0091
600 DISABILITY 179 0.0090
601 ULCER 144 0.0090
602 ADVERSE REACTION 120 0.0090
603 PROCEDURAL PAIN 251 0.0090
604 DRUG TOXICITY 123 0.0090
605 IMPAIRED HEALING 296 0.0090
606 DYSPHAGIA 855 0.0090
607 INTRAOCULAR PRESSURE INCREASED 115 0.0090
608 UPPER RESPIRATORY TRACT INFECTION 415 0.0090
609 SWELLING 840 0.0090
610 HYPOPHAGIA 228 0.0089
611 VISUAL ACUITY REDUCED 296 0.0089
612 PROTEINURIA 169 0.0089
613 CARDIOMYOPATHY 131 0.0089
614 POLLAKIURIA 368 0.0088
615 ATRIAL FIBRILLATION 859 0.0088
616 RENAL DISORDER 410 0.0088
617 MOBILITY DECREASED 632 0.0088
618 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 480 0.0087
619 RASH ERYTHEMATOUS 418 0.0087
620 SUBARACHNOID HAEMORRHAGE 89 0.0087
621 INTESTINAL OBSTRUCTION 329 0.0087
622 SUICIDAL IDEATION 798 0.0087
623 CYST 108 0.0087
624 HEART RATE INCREASED 862 0.0087
625 HYPERSENSITIVITY 1609 0.0087
626 SHOCK 199 0.0086
627 LIP SWELLING 288 0.0086
628 PNEUMOTHORAX 137 0.0086
629 BLOOD CALCIUM DECREASED 97 0.0086
630 NODULE 112 0.0086
631 FOOT DEFORMITY 95 0.0086
632 BONE MARROW FAILURE 174 0.0086
633 DYSPNOEA 4837 0.0085
634 VISION BLURRED 1172 0.0085
635 ARTHRITIS 671 0.0085
636 NEUTROPHIL COUNT DECREASED 347 0.0085
637 COUGH 2386 0.0085
638 HEMIPARESIS 144 0.0085
639 HALLUCINATION, AUDITORY 135 0.0085
640 URTICARIA 1423 0.0085
641 PNEUMONIA ASPIRATION 212 0.0085
642 RETINAL DETACHMENT 78 0.0085
643 SUPRAVENTRICULAR TACHYCARDIA 81 0.0085
644 RASH GENERALISED 219 0.0084
645 PANCREATITIS ACUTE 189 0.0084
646 ORAL HERPES 164 0.0084
647 PERITONITIS 174 0.0084
648 HYPERHIDROSIS 1081 0.0084
649 BONE PAIN 491 0.0084
650 BRAIN INJURY 84 0.0084
651 EJECTION FRACTION DECREASED 130 0.0084
652 VISUAL IMPAIRMENT 1033 0.0083
653 ABDOMINAL DISTENSION 870 0.0083
654 EMPHYSEMA 84 0.0083
655 GASTRIC DISORDER 285 0.0083
656 CONSTIPATION 1811 0.0083
657 SINUSITIS 850 0.0083
658 PNEUMONITIS 225 0.0083
659 CONJUNCTIVITIS 153 0.0082
660 GRAND MAL CONVULSION 76 0.0082
661 SYNCOPE 821 0.0082
662 RESTLESS LEGS SYNDROME 149 0.0082
663 TASTE DISORDER 166 0.0082
664 FLUID OVERLOAD 119 0.0082
665 MALAISE 3578 0.0082
666 DECREASED APPETITE 1893 0.0081
667 LYMPHOPENIA 115 0.0081
668 DYSARTHRIA 306 0.0081
669 HEPATIC ENZYME INCREASED 554 0.0081
670 ABDOMINAL DISCOMFORT 1362 0.0081
671 MIGRAINE 775 0.0081
672 ASPIRATION 88 0.0080
673 WEIGHT FLUCTUATION 84 0.0080
674 LIVER INJURY 197 0.0080
675 PULMONARY EMBOLISM 762 0.0080
676 THROMBOTIC MICROANGIOPATHY 78 0.0080
677 HYPOTENSION 1602 0.0080
678 STOMATITIS 484 0.0080
679 AMNESIA 516 0.0079
680 PHARYNGEAL OEDEMA 122 0.0079
681 OROPHARYNGEAL PAIN 734 0.0079
682 COGNITIVE DISORDER 370 0.0079
683 ANOREXIA 102 0.0079
684 PERIPHERAL SWELLING 1219 0.0079
685 RASH 3444 0.0079
686 RASH PAPULAR 177 0.0079
687 VERTIGO 481 0.0079
688 FATIGUE 6142 0.0079
689 LETHARGY 453 0.0079
690 PERICARDIAL EFFUSION 182 0.0079
691 IMPAIRED GASTRIC EMPTYING 107 0.0078
692 RIB FRACTURE 161 0.0078
693 ERYTHEMA 1606 0.0078
694 RED BLOOD CELL COUNT DECREASED 223 0.0078
695 METASTASES TO BONE 128 0.0078
696 INTENTIONAL PRODUCT USE ISSUE 683 0.0078
697 CORONARY ARTERY DISEASE 236 0.0078
698 MANIA 128 0.0078
699 CYANOSIS 122 0.0077
700 HAIR COLOUR CHANGES 96 0.0077
701 DRY EYE 385 0.0077
702 DERMATITIS ALLERGIC 97 0.0077
703 GASTROENTERITIS VIRAL 139 0.0077
704 RASH PRURITIC 417 0.0077
705 HYPOCALCAEMIA 145 0.0077
706 LIMB INJURY 208 0.0076
707 HYPERTENSION 1621 0.0076
708 POOR QUALITY SLEEP 164 0.0076
709 HEPATIC CIRRHOSIS 143 0.0076
710 FLUID RETENTION 387 0.0076
711 PNEUMOCYSTIS JIROVECII PNEUMONIA 76 0.0076
712 NO THERAPEUTIC RESPONSE 92 0.0075
713 CARDIOGENIC SHOCK 108 0.0075
714 PRESYNCOPE 183 0.0075
715 CARDIAC FAILURE CONGESTIVE 604 0.0075
716 NAUSEA 5948 0.0075
717 ADRENAL INSUFFICIENCY 91 0.0075
718 SEROTONIN SYNDROME 144 0.0075
719 FOOT FRACTURE 142 0.0075
720 RESPIRATORY DISORDER 224 0.0075
721 SCIATICA 119 0.0075
722 DERMATITIS CONTACT 85 0.0074
723 STATUS EPILEPTICUS 84 0.0074
724 RASH MACULAR 260 0.0074
725 CYTOPENIA 91 0.0074
726 PLATELET COUNT DECREASED 792 0.0074
727 BRONCHOSPASM 106 0.0074
728 CONTUSION 714 0.0074
729 INITIAL INSOMNIA 76 0.0074
730 OSTEONECROSIS OF JAW 183 0.0074
731 INFUSION RELATED REACTION 490 0.0074
732 HYPOTHYROIDISM 236 0.0074
733 DIZZINESS 3677 0.0074
734 SCAB 84 0.0074
735 DYSKINESIA 298 0.0073
736 OXYGEN SATURATION DECREASED 412 0.0073
737 HYPERCALCAEMIA 90 0.0073
738 PALLOR 198 0.0073
739 CHEST DISCOMFORT 744 0.0073
740 MOVEMENT DISORDER 233 0.0072
741 THERAPEUTIC PRODUCT EFFECT DECREASED 325 0.0072
742 LIVER DISORDER 320 0.0072
743 SKIN DISORDER 239 0.0072
744 COLD SWEAT 126 0.0071
745 MELAENA 157 0.0071
746 PLATELET COUNT INCREASED 93 0.0071
747 MYELODYSPLASTIC SYNDROME 103 0.0071
748 DEPRESSED MOOD 376 0.0071
749 INTERSTITIAL LUNG DISEASE 344 0.0071
750 BIPOLAR DISORDER 77 0.0071
751 FLATULENCE 401 0.0071
752 HYPOAESTHESIA ORAL 106 0.0070
753 HAEMATEMESIS 178 0.0070
754 BLOOD PRESSURE DECREASED 466 0.0070
755 PULMONARY OEDEMA 314 0.0070
756 BRADYCARDIA 371 0.0070
757 PRURITUS GENERALISED 151 0.0070
758 BLOOD CREATINE PHOSPHOKINASE INCREASED 201 0.0070
759 HYPOGLYCAEMIA 337 0.0069
760 OCULAR DISCOMFORT 78 0.0069
761 PULMONARY FIBROSIS 133 0.0069
762 WRIST FRACTURE 83 0.0069
763 FEELING ABNORMAL 1657 0.0069
764 EYE SWELLING 257 0.0069
765 BACK INJURY 75 0.0069
766 THIRST 123 0.0069
767 SYNOVITIS 124 0.0069
768 CARDIAC ARREST 567 0.0069
769 MUSCLE RIGIDITY 82 0.0068
770 MIDDLE INSOMNIA 128 0.0068
771 ORAL DISCOMFORT 95 0.0068
772 DIALYSIS 97 0.0068
773 HYPERGLYCAEMIA 249 0.0068
774 LOCAL SWELLING 119 0.0068
775 GINGIVAL BLEEDING 93 0.0068
776 HAND DEFORMITY 89 0.0068
777 BLOOD TRIGLYCERIDES INCREASED 119 0.0067
778 EMOTIONAL DISORDER 206 0.0067
779 EPILEPSY 204 0.0067
780 BONE DENSITY DECREASED 209 0.0067
781 UNRESPONSIVE TO STIMULI 172 0.0067
782 PRODUCT PRESCRIBING ISSUE 145 0.0066
783 DRY MOUTH 538 0.0066
784 PULMONARY HYPERTENSION 138 0.0066
785 HAEMORRHAGE INTRACRANIAL 99 0.0066
786 HEADACHE 4145 0.0066
787 WHITE BLOOD CELL COUNT DECREASED 716 0.0066
788 MEMORY IMPAIRMENT 906 0.0066
789 LUNG DISORDER 322 0.0066
790 BLOOD PRESSURE INCREASED 997 0.0065
791 NASAL CONGESTION 383 0.0065
792 LYMPHOCYTE COUNT DECREASED 115 0.0065
793 EATING DISORDER 138 0.0065
794 TOXICITY TO VARIOUS AGENTS 1090 0.0065
795 IMMUNODEFICIENCY 96 0.0064
796 GASTROINTESTINAL HAEMORRHAGE 538 0.0064
797 ANGINA PECTORIS 184 0.0064
798 DELUSION 99 0.0064
799 HYPOACUSIS 274 0.0064
800 TOOTH LOSS 131 0.0063
801 GASTRIC ULCER 120 0.0063
802 LACTIC ACIDOSIS 204 0.0063
803 INFUSION SITE PAIN 81 0.0063
804 FEELING HOT 385 0.0063
805 KNEE ARTHROPLASTY 132 0.0063
806 DEPRESSED LEVEL OF CONSCIOUSNESS 248 0.0063
807 PRURITUS 2402 0.0062
808 APATHY 91 0.0062
809 RESPIRATORY TRACT CONGESTION 99 0.0062
810 EPISTAXIS 465 0.0062
811 CARDIAC FAILURE 499 0.0062
812 HYPERSOMNIA 178 0.0062
813 BLOOD COUNT ABNORMAL 94 0.0062
814 PROSTATIC SPECIFIC ANTIGEN INCREASED 85 0.0062
815 HAIR TEXTURE ABNORMAL 82 0.0061
816 SINUS DISORDER 121 0.0061
817 SNEEZING 137 0.0061
818 DISCOMFORT 372 0.0061
819 BRAIN OEDEMA 77 0.0061
820 SKIN DISCOLOURATION 280 0.0061
821 ACUTE MYOCARDIAL INFARCTION 179 0.0061
822 LUNG NEOPLASM MALIGNANT 248 0.0060
823 CONVULSION 345 0.0060
824 VIRAL INFECTION 200 0.0060
825 POST PROCEDURAL COMPLICATION 115 0.0060
826 DERMATITIS 125 0.0060
827 HERNIA 115 0.0059
828 EYE DISORDER 195 0.0059
829 LABORATORY TEST ABNORMAL 175 0.0059
830 FEEDING DISORDER 119 0.0059
831 DYSGEUSIA 435 0.0058
832 NERVOUSNESS 305 0.0058
833 BASAL CELL CARCINOMA 91 0.0058
834 RHINORRHOEA 377 0.0058
835 CENTRAL NERVOUS SYSTEM LESION 80 0.0058
836 SEIZURE 671 0.0058
837 PRODUCT PRESCRIBING ERROR 138 0.0058
838 CRYING 210 0.0058
839 RETCHING 123 0.0058
840 CATARACT 336 0.0056
841 LOSS OF CONSCIOUSNESS 721 0.0056
842 PAIN OF SKIN 151 0.0056
843 PSYCHOMOTOR HYPERACTIVITY 93 0.0056
844 DISEASE PROGRESSION 658 0.0056
845 SUBDURAL HAEMATOMA 79 0.0055
846 HERPES ZOSTER 317 0.0055
847 TREATMENT FAILURE 457 0.0055
848 SPEECH DISORDER 289 0.0055
849 PANCREATITIS 291 0.0055
850 GLOSSODYNIA 123 0.0055
851 ANKLE FRACTURE 85 0.0055
852 DISEASE RECURRENCE 261 0.0055
853 HOT FLUSH 412 0.0055
854 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 387 0.0054
855 BLOOD PRESSURE ABNORMAL 108 0.0054
856 SEDATION 142 0.0054
857 ALTERED STATE OF CONSCIOUSNESS 117 0.0054
858 OFF LABEL USE 4716 0.0054
859 AGEUSIA 134 0.0054
860 DYSTONIA 104 0.0054
861 ANAPHYLACTIC SHOCK 138 0.0053
862 BLOOD CHOLESTEROL INCREASED 249 0.0053
863 FULL BLOOD COUNT DECREASED 107 0.0053
864 THROAT IRRITATION 238 0.0053
865 FALL 1760 0.0053
866 HIP FRACTURE 170 0.0053
867 HEPATIC FUNCTION ABNORMAL 196 0.0052
868 CEREBRAL HAEMORRHAGE 187 0.0052
869 TOOTH DISORDER 116 0.0052
870 DIABETES MELLITUS INADEQUATE CONTROL 92 0.0052
871 THYROID DISORDER 80 0.0052
872 ANOSMIA 75 0.0052
873 ALOPECIA 1017 0.0052
874 METASTASES TO LIVER 91 0.0052
875 BLOOD POTASSIUM INCREASED 84 0.0052
876 ABNORMAL DREAMS 142 0.0051
877 CARDIO-RESPIRATORY ARREST 215 0.0051
878 THERAPY NON-RESPONDER 231 0.0051
879 PRODUCT USE IN UNAPPROVED INDICATION 1268 0.0051
880 DIABETES MELLITUS 389 0.0051
881 WEIGHT INCREASED 1139 0.0051
882 LIVER FUNCTION TEST INCREASED 109 0.0051
883 NASOPHARYNGITIS 935 0.0051
884 THROMBOSIS 408 0.0051
885 TRANSIENT ISCHAEMIC ATTACK 171 0.0051
886 INFLUENZA 564 0.0051
887 SKIN EXFOLIATION 425 0.0050
888 RESPIRATORY ARREST 137 0.0050
889 LACRIMATION INCREASED 150 0.0050
890 SOMNOLENCE 986 0.0049
891 HAEMORRHAGE 504 0.0048
892 TYPE 2 DIABETES MELLITUS 162 0.0048
893 UNEVALUABLE EVENT 364 0.0048
894 SYSTEMIC LUPUS ERYTHEMATOSUS 169 0.0048
895 INFLUENZA LIKE ILLNESS 390 0.0047
896 DEMENTIA 132 0.0047
897 ERECTILE DYSFUNCTION 120 0.0047
898 EXTRAPYRAMIDAL DISORDER 116 0.0047
899 BLINDNESS 190 0.0047
900 OCULAR HYPERAEMIA 221 0.0047
901 ADVERSE DRUG REACTION 418 0.0046
902 ABNORMAL BEHAVIOUR 182 0.0046
903 TREATMENT NONCOMPLIANCE 248 0.0045
904 GLAUCOMA 87 0.0045
905 ILLNESS 465 0.0045
906 MOOD ALTERED 123 0.0045
907 TARDIVE DYSKINESIA 127 0.0045
908 ERUCTATION 86 0.0044
909 MOOD SWINGS 141 0.0044
910 PRODUCT USE ISSUE 815 0.0043
911 EYE IRRITATION 248 0.0043
912 EXPOSURE DURING PREGNANCY 264 0.0042
913 UPPER LIMB FRACTURE 84 0.0042
914 HEAD INJURY 132 0.0042
915 THERAPEUTIC RESPONSE SHORTENED 136 0.0041
916 ILL-DEFINED DISORDER 242 0.0040
917 LOWER LIMB FRACTURE 76 0.0040
918 DRUG INEFFECTIVE 5210 0.0039
919 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 710 0.0039
920 SKIN BURNING SENSATION 277 0.0039
921 ECZEMA 202 0.0039
922 COVID-19 672 0.0038
923 CARDIAC DISORDER 358 0.0038
924 EYE PRURITUS 126 0.0037
925 ROAD TRAFFIC ACCIDENT 156 0.0037
926 AGGRESSION 185 0.0037
927 OSTEONECROSIS 120 0.0036
928 THERAPY CESSATION 187 0.0036
929 RHEUMATOID ARTHRITIS 410 0.0036
930 IRRITABILITY 215 0.0036
931 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 83 0.0036
932 MYOCARDIAL INFARCTION 620 0.0036
933 SKIN CANCER 76 0.0035
934 COMA 165 0.0035
935 PLASMA CELL MYELOMA 134 0.0034
936 SURGERY 198 0.0034
937 FLUSHING 341 0.0034
938 DIABETIC KETOACIDOSIS 78 0.0032
939 ANGER 109 0.0032
940 MATERNAL EXPOSURE DURING PREGNANCY 287 0.0032
941 VAGINAL HAEMORRHAGE 139 0.0032
942 PSORIATIC ARTHROPATHY 129 0.0032
943 DRY SKIN 417 0.0031
944 MALIGNANT NEOPLASM PROGRESSION 319 0.0031
945 INTENTIONAL PRODUCT MISUSE 269 0.0031
946 CEREBRAL INFARCTION 75 0.0031
947 ADVERSE EVENT 281 0.0030
948 PREMATURE BABY 91 0.0030
949 NEOPLASM PROGRESSION 105 0.0030
950 CEREBROVASCULAR ACCIDENT 500 0.0029
951 BLOOD GLUCOSE DECREASED 139 0.0029
952 FEMUR FRACTURE 89 0.0029
953 HOSPITALISATION 436 0.0028
954 SUICIDE ATTEMPT 167 0.0028
955 PRODUCT DOSE OMISSION ISSUE 789 0.0027
956 PRODUCT DOSE OMISSION 172 0.0026
957 BLOOD GLUCOSE INCREASED 489 0.0026
958 NEOPLASM MALIGNANT 168 0.0025
959 THERAPEUTIC RESPONSE DECREASED 148 0.0024
960 DRUG ABUSE 203 0.0024
961 OVERDOSE 521 0.0024
962 MULTIPLE SCLEROSIS 115 0.0024
963 DEATH 2001 0.0023
964 COMPLETED SUICIDE 192 0.0023
965 THERAPEUTIC RESPONSE UNEXPECTED 103 0.0023
966 MULTIPLE SCLEROSIS RELAPSE 153 0.0022
967 THERAPY INTERRUPTED 154 0.0022
968 ACNE 158 0.0021
969 INCORRECT DOSE ADMINISTERED 447 0.0020
970 DRUG DOSE OMISSION 308 0.0019
971 DEVICE DISLOCATION 80 0.0018
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 126 0.0018
973 PSORIASIS 231 0.0018
974 SKIN IRRITATION 79 0.0017
975 FOETAL EXPOSURE DURING PREGNANCY 135 0.0017
976 DRUG EFFECT DECREASED 87 0.0016
977 UNDERDOSE 116 0.0016
978 INJECTION SITE SWELLING 114 0.0015
979 INTENTIONAL OVERDOSE 94 0.0015
980 DRUG WITHDRAWAL SYNDROME 128 0.0015
981 NO ADVERSE EVENT 247 0.0014
982 INJECTION SITE PRURITUS 88 0.0013
983 INJECTION SITE REACTION 90 0.0013
984 PROSTATE CANCER 104 0.0013
985 INJECTION SITE PAIN 392 0.0013
986 INJECTION SITE ERYTHEMA 152 0.0012
987 DRUG DEPENDENCE 196 0.0012
988 INJECTION SITE BRUISING 96 0.0012
989 INJECTION SITE HAEMORRHAGE 96 0.0012
990 DEVICE ISSUE 103 0.0011
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 214 0.0011
992 PRODUCT QUALITY ISSUE 143 0.0011
993 BREAST CANCER 76 0.0008